Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis? by Agland, S. et al.
Short report
Can a stress management programme reduce
stress and improve quality of life in people
diagnosed with multiple sclerosis?
Susan Agland , Amanda Lydon, Sally Shaw, Rodney Lea, Sheila Mortimer-Jones and
Jeannette Lechner-Scott
Abstract
Background: Despite evidence of perceived stress as a risk factor for multiple sclerosis activity, the
evidence for managing stress is limited.
Objective To evaluate a stress management programme on perceived stress and quality of life, over
6 months.
Methods: One hundred people with multiple sclerosis were randomly assigned to either a stress man-
agement programme of mindfulness, meditation and progressive muscle relaxation, or wait list.
Perceived stress and quality of life were assessed at three intervals across 6 months. Salivary cortisol
levels were assessed at two intervals: baseline and first follow-up.
Results: The stress management programme did not significantly reduce perceived stress, when com-
paring mean scores. Secondary analysis using median scores found a significant improvement for
quality of life, favouring the intervention group.
Conclusion: Stress management had no significant effect on the primary outcome of perceived stress
but did improve quality of life in a secondary analysis of median scores.
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Introduction
Multiple sclerosis (MS) is a complex neurological
disorder that is not yet entirely understood. The inci-
dence and prevalence of MS are rapidly increasing1
and people with MS are encouraged to modify life-
style factors that may contribute to an increased risk
of MS disease.2 Perceived stress and emotion-related
coping strategies may be indicators for poor adjust-
ment to having MS,3 which can influence the risk of
anxiety and depression. Furthermore, changes in the
neuroendocrine immune network (specifically the
hypo–pituitary–adrenal axis) have been postulated
as a pathway that mediates MS disease progression.4
Salivary cortisol can be used as a measure of stress
response. Increased stress may augment the risk of
MS relapse5,6 and negatively affect the quality of
life.7 This project aimed to investigate the effect of
a stress management programme on perceived stress
and quality of life in MS.
Significance of the study
Despite considerable literature describing the role
and effect of stress in MS there are few studies
that have evaluated the effect of stress management
programmes on perceived stress. Managing stress
might positively affect MS.7–11 Each of these studies
used small cohorts of people with MS and relied on
subjective assessments to measure stress.
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This study will address the following research
questions:
1. Can a stress management intervention reduce per-
ceived stress in people with MS?
2. Can a stress management programme improve
quality of life for people with MS?
3. Can the effect of a stress management interven-
tion be maintained beyond the intervention
programme?
Methods
Participants were randomly recruited from a MS spe-
cialist centre. Ethical approval was provided by
Hunter New England local health district human
research ethics committee (approval number 14/06/
18/4.02) and Murdoch University human research
ethics committee (approval number 2014/118).
Participants were not compensated for their time.
Data were collected using repeated measures, at base-
line, at 1 month and 6 months post-baseline and
included salivary cortisol levels and self-reported
levels of perceived stress. Salivary cortisol was col-
lected using the Salivette collection system. Samples
were collected at 08.00, 14.00 and 20.00 hours on day
1 and repeated on week 4 of the study. Participants
were asked to abstain from eating, drinking, taking
medications, or vigorous exercise for 30 minutes
before the sample was collected. The average of the
three samples collected was used for analysis.
Perceived stress was assessed using the depression,
anxiety and stress scale (DASS21) and stress visual
analogue scale (sVAS). Quality of life was assessed
using the multiple sclerosis international quality of
life (MusiQoL) questionnaire.
Inclusion/exclusion criteria
Included participants had a diagnosis of MS and
were 18–70 years of age. Exclusion criteria com-
prised significant medical and/or psychological ill-
ness, MS relapse within 1 month of enrolment in the
study, cognitive dysfunction, inability to read or
write English, and severe muscular spasms inhibit-
ing participation in progressive muscle relaxation
(PMR) exercises.
Intervention
The intervention was delivered by the study investi-
gator, an MS clinical nurse specialist. Formal, spe-
cific training was undertaken – mindfulness-
integrated cognitive behaviour therapy. The specific
programme delivered for this project was designed
with input from an MS specialist psychologist, a
psychologist specialising in mindfulness and medi-
tation and an MS specialist neurologist. Additional
written resources were provided by another MS spe-
cialist psychologist (F Foley, 2012). All of the ses-
sions were delivered by the MS clinical
nurse specialist.
At the baseline visit intervention participants were
provided with an informational package consisting
of an educational brochure on stress in MS entitled
‘Taming Stress in MS: Staying Well’ (F. Foley,
2012), a meditation compact disc with a 20-minute
guided meditation and 10-minute guided PMR and
mindfulness exercises including diaphragmatic
breathing and body scanning. One-on-one sessions
continued weekly for another 3 weeks with the MS
clinical nurse specialist. Participants were encour-
aged to perform meditation and PMR on a daily
basis for 20 minutes per day for the study period
of 6 months. Programme adherence was recorded
in a daily diary. Key points for data collection
were baseline and 1 month after (which coincided
with the end of the face-to-face learning sessions) –
surveys and salivary cortisol and baseline to 6
months post-baseline – surveys.
Results
For the first follow-up time point (i.e. 1 month post-
baseline) 82% of whole datasets were available for
analysis. By the second follow-up time point (i.e. 6
months post-baseline) only 42% of whole datasets
were available for analysis. Complete cortisol data-
sets were available for 49% of participants, equally
split between intervention and wait list participants.
Intervention and wait list groups had a similar dis-
tribution of age, gender and MS type, see Table 1.
Means (see Table 2) were compared across time
points using the general linear model repeated meas-
ures analysis of variance. An alpha level of 0.05 was
used as the significance threshold.
Given the presence of several outliers, a Mann–
Whitney U-test was performed to compare medians
between the intervention and non-intervention
groups, with an alpha level of 0.05 used as the sta-
tistical significance threshold. In this secondary
analysis, median score comparison did reflect a sig-
nificant effect of intervention on the case group for
quality of life (P¼ 0.0021), although not for sVAS
(P> 0.1) nor DASS21 (P> 0.1).
Discussion
PMR, meditation and mindfulness did not signifi-
cantly reduce stress in the cohort, but did improve
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quality of life. This outcome represents relative
inconsistency with the existing evidence for similar
stress management strategies. The small trend for
improvement in perceived stress (sVAS and
DASS21) over time in the intervention group is mir-
rored by the wait list group, further diminishing the
effect of stress management exercises. The third
research question focusing on the longer term
effect found that any effect of the intervention ini-
tially is reduced over time, i.e. beyond the regular
contact period with the study team, from month 1 to
month 6.
Study strong points
The two robust features of this study are a larger
study cohort and using salivary cortisol for an objec-
tive measure of intervention effect. In design, this
study reflected the day-to-day realities of a largely
self-managed intervention, and barriers to routinely
and regularly performing stress management exer-
cises were identified.
Study weak points
Half of the population began and finished the study
with normal stress levels; 49% of cortisol sets
Table 1. Participant demographics.
Number, n (%) 50 (50) 50 (50)
Women, n (%) 44 (88) 42 (84)
Men, n (%) 6 (12) 8 (16)
Median age in years (range) 44 (22–67) 43 (19–72)
MS type: RRMS, n (%) 46 (92) 44
MS type: SPMS, n (%) 4 (8) 4
MS type: PPMS, n (%) 0 (0) 2
MS duration average in years (range) 9.8 (1–35) 9.0 (1–37)
EDSS median (range) 2.6 (0.0–6.5) 2.7 (0.0–6.5)
RRMS: relapsing–remitting multiple sclerosis; SPMS: secondary progressive multiple sclerosis; PPMS: primary
progressive multiple sclerosis; EDSS: Expanded Disability Status Scale.
Table 2. Study results, primary outcome: mean scores.







Stress VAS Intervention group 4.4 3.8 (P¼0.8) 2.9 (P¼0.3) 0–10
Wait list group 3.7 4.2 3.7
Stress of
DASS21





Wait list group 14.3 13.1 10.3




06.00 to 08.00 hours –
5.5 to 28.9 nm/L
18.00 to 20.00 hours –
1.1 to 11.6 nm/L
midnight – <7.0 nm/L
Wait list group 5.1 nmol/L 7.6 nmol/L –
MusiQoL Intervention group 63.9 67.2 (P¼0.3) 73.3 (P¼0.3) 0–100
Wait list group 67.3 70.8 69.2
aSalivary cortisol measure is the average of three samples collected at 08.00, 14.00 and 20.00 hours.
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(n¼ 26 intervention and n¼ 26 wait list) were com-
pleted for analysis. A further 11 intervention partic-
ipants and nine wait list participants completed some
but not all of the samples required, and so were not
included for analysis. Adherence to home practice of
the stress management exercises was performed as
scheduled by less than half of the cohort.
Conclusions
The current study has shown that in a random cohort
of people with MS (with a large range of ages and
disability) performing mindfulness, meditation
and PMR had no significant effect on perceived
levels of stress but may influence quality of life.
Future studies should focus on populations of
people with MS who have at baseline objectively
derived increased stress, and barriers to adher-
ence considered.
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